Neuromonics: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 32: | Line 32: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 20:10, 17 March 2025
Neuromonics is a form of tinnitus treatment that uses a combination of acoustic stimulation and cognitive behavioral therapy. The treatment is designed to interact, interrupt and desensitize tinnitus disturbance for long term benefit.
History[edit]
Neuromonics was developed by Paul Davis, an Australian audiologist, in the late 1990s. The treatment was initially tested in Australia before being introduced to the United States in 2003.
Treatment[edit]
The Neuromonics treatment involves the use of a device that delivers a customized neural stimulus combined with specific music tracks. The device is worn for a few hours each day, and the treatment typically lasts for six months. The treatment aims to desensitize the patient's tinnitus perception.
Effectiveness[edit]
Several studies have shown that Neuromonics can be an effective treatment for tinnitus. A study published in the journal Ear and Hearing in 2008 found that 90% of patients experienced a significant reduction in tinnitus disturbance.
See also[edit]
References[edit]
<references />
